Precision medicine and the future of cardiovascular diseases: a clinically oriented comprehensive review

Y Sethi, N Patel, N Kaka, O Kaiwan, J Kar… - Journal of clinical …, 2023‏ - mdpi.com
Cardiac diseases form the lion's share of the global disease burden, owing to the paradigm
shift to non-infectious diseases from infectious ones. The prevalence of CVDs has nearly …

Nanoparticle-based drug delivery systems in cancer: A focus on inflammatory pathways

AR Afshari, M Sanati, H Mollazadeh… - Seminars in cancer …, 2022‏ - Elsevier
It has become necessary to accept the clinical reality of therapeutic agents targeting the
cancer-associated immune system. In recent decades, several investigations have …

An injectable co-assembled hydrogel blocks reactive oxygen species and inflammation cycle resisting myocardial ischemia-reperfusion injury

X Liao, X Song, J Li, L Li, X Fan, Q Qin, C Zhong… - Acta biomaterialia, 2022‏ - Elsevier
The overproduction of reactive oxygen species (ROS) and burst of inflammation following
cardiac ischemia–reperfusion (I/R) are the leading causes of cardiomyocyte injury …

Nanomaterials responsive to endogenous biomarkers for cardiovascular disease theranostics

C Wei, Z Jiang, C Li, P Li, Q Fu - Advanced Functional Materials, 2023‏ - Wiley Online Library
Cardiovascular disease (CVD) is the number one cause of death worldwide, which propels
the development of advanced technologies for CVD diagnosis and treatment. Biomarker …

[HTML][HTML] An injectable and conductive TEMPOL/polypyrrole integrated peptide co-assembly hydrogel promotes functional maturation of cardiomyocytes for myocardial …

J Zhan, X Liao, X Fan, J Zhang, H Li, Y Cai… - Composites Part B …, 2022‏ - Elsevier
A cell-implantation strategy offers a promising paradigm for cardiac repair after myocardial
infarction (MI). However, the hostile reactive oxygen species (ROS) microenvironment in …

Baicalin-peptide supramolecular self-assembled nanofibers effectively inhibit ferroptosis and attenuate doxorubicin-induced cardiotoxicity

Y Zeng, X Liao, Y Guo, F Liu, F Bu, J Zhan… - Journal of Controlled …, 2024‏ - Elsevier
Doxorubicin, an anthracycline chemotherapeutic agent, elicits a deleterious cardiotoxicity
known as doxorubicin-induced cardiomyopathy (DIC) that circumscribes its chemotherapy …

Nanofibers for the immunoregulation in biomedical applications

L Fu, Q Feng, Y Chen, J Fu, X Zhou, C He - Advanced Fiber Materials, 2022‏ - Springer
Despite great efforts and achievement of nanomaterials in immune-associated diseases, the
selection of appropriate nanomaterials and preparation technology remain some challenges …

Fabrication of blended nanofibrous cardiac patch transplanted with TGF-β3 and human umbilical cord MSCs-derived exosomes for potential cardiac regeneration after …

P **, S Guan, C Ning, T Yang, Y Zhao… - … , Biology and Medicine, 2023‏ - Elsevier
Acute myocardial infarction (AMI) is a common cardiovascular condition that progressively
results in heart failure. In the present study, we have designed to load transforming growth …

MMP 9-instructed assembly of bFGF nanofibers in ischemic myocardium to promote heart repair

Y Wang, D Wang, C Wu, B Wang, S He, H Wang… - …, 2022‏ - pmc.ncbi.nlm.nih.gov
Background: The only effective treatment for myocardial infarction (MI) is the timely
restoration of coronary blood flow in the infarcted area, but further reperfusion exacerbates …

[HTML][HTML] Robust drug bioavailability and safety for rheumatoid arthritis therapy using D-amino acids-based supramolecular hydrogels

S Ma, S Gu, J Zhang, W Qi, Z Lin, W Zhai, J Zhan, Q Li… - Materials Today Bio, 2022‏ - Elsevier
Long-term use of disease-modifying anti-rheumatic drugs (DMARDs) such as methotrexate
(MTX) shows clinical benefits for rheumatoid arthritis (RA) treatment. However, there are …